Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001219039-04-000004
Filing Date
2004-03-23
Accepted
2004-03-23 12:52:39
Documents
1
Period of Report
2004-03-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 39906
  Complete submission text file 0001219039-04-000004.txt   41561
Mailing Address
Business Address 1124 COLUMBIA STREET SUITE 130 SEATTLE WA 98104 2062626200
XCYTE THERAPIES INC (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address ARCH VENTURE PARTNERS 8725 W HIGGINS RD STE 290 CHICAGO IL 60631 7733806600
CRANDELL KEITH (Reporting) CIK: 0001219039 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 04684454